# Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/comparison-of-acute-toxicity-and-mortality-after-two-different-dosing-regimens/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Laura Alwan,Kenneth F. Grossmann,Daniel S. Sageser,Joan Van Atta,Neeraj Agarwal,Jeffrey A. Gilreath |
| Citations | 56 |
| DOI | 10.1007/s11523-013-0276-7 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2050529682 |
| PMID | 23609056 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Jeffrey A. Gilreath](https://scholariq.org/researchers/jeffrey-a-gilreath/)

## Paper journal

- [Targeted Oncology](https://scholariq.org/journals/targeted-oncology/)

## Paper primary topic

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Paper topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.